Termination of ventricular tachycardia by an implantable atrial pacemaker and external pacemaker activator

An atrial pacemaker was implanted in a patient who had dilated cardiomyopathy, sinus node dysfunction, and drug-resistant ventricular tachycardia (VT). VT episodes were terminated by atrial overdrive pacing using an implanted pacemaker and a newly developed hand-held external programmer/transmitter....

Full description

Saved in:
Bibliographic Details
Published inPacing and clinical electrophysiology Vol. 8; no. 4; p. 532
Main Authors Tanabe, A, Ikeda, H, Fujiyama, M, Furuta, Y, Matsumura, J, Ohbayashi, J, Utsu, F, Toshima, H
Format Journal Article
LanguageEnglish
Published United States 01.07.1985
Subjects
Adult
Cardiac Pacing, Artificial - methods
Humans
Male
Pacemaker, Artificial
Tachycardia - therapy
Online AccessGet more information

Cover

More Information
Summary:An atrial pacemaker was implanted in a patient who had dilated cardiomyopathy, sinus node dysfunction, and drug-resistant ventricular tachycardia (VT). VT episodes were terminated by atrial overdrive pacing using an implanted pacemaker and a newly developed hand-held external programmer/transmitter. Although successful cases of termination of intractable VT by ventricular pacing have recently been reported, the ventricular method might increase the risk of accelerating VT. Atrial overdrive pacing is a safer method since it minimizes the possibility of tachycardia acceleration and, combined with antiarrhythmic drugs, it appeared to be a unique and useful approach for the treatment of drug-resistant VT.
ISSN:0147-8389
DOI:10.1111/j.1540-8159.1985.tb05855.x